Surya Pharma to Market Crocs Medical Footwear in India

by Kathy Jones on  May 28, 2010 at 9:17 PM Corporate News
RSS Email Print This Page Comment
Font : A-A+

Surya Pharmaceuticals has announced that it has signed a deal with US Company Crocs, under which it will market the latter's medical footwear range in India.
 Surya Pharma to Market Crocs Medical Footwear in India
Surya Pharma to Market Crocs Medical Footwear in India

Crocs have a range of medical footwear for people with arthritis and diabetes and sell a range called "Crocs Rx Medical."   Hari Om Bhatia, President Surya Pharmaceuticals said that this deal was part of more elaborate plans to introduce international brands in India.

Surya plans to sell 6.5 lakh pairs over the next two years and is confident of attaining the target as the diabetic population is on the rise in India.

Mr Bhatia said the footwear would be launched in 15 cities initially through the company's Viva retail outlets.


Source: Medindia
RAS

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Athletes Foot 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive